Higher inflation in the U.S. might end up forcing President Trump to limit trade tariffs, according to Michael Hartnett, chief investment strategist at BofA. Hartnett said that 3% U.S. CPI in January ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

Bleakley Financial Group LLC lowered its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% during the 4th ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations.

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Coburn, sums it up, succinctly saying, “It’s a twisty, wild ride with heart and humor. “ ‘The Hunting Party’ airs Mondays at 20pm e/p on NBC, and is available for streaming the following ...

the heart of our concern, being what steps council is taking to address conflicts that arise," she said. "And then also … ensuring that we can say both to the members of EPS and to the public ...